Bio-Techne (TECH) returns by market regime
In past Mildly Off markets, TECH's typical 3-month return was −0.1%, rising 50% of the time, below its +2.9% across all markets.
TECH: typical return and usual range
Tick: typical return · Bar ends: usual range · Dashed line: 0% · Arrow: runs past the edge
Typical return +1.1%, usual range −8% to +14%.How often it rose: 55%
Typical return +0.8%, usual range −7% to +10%.How often it rose: 55%
Typical return +0.8%, usual range −8% to +9%.How often it rose: 56%
Typical return +0.1%, usual range −12% to +9%.How often it rose: 50%
Typical return +2.3%, usual range −7% to +13%.How often it rose: 61%
Typical return +3.2%, usual range −9% to +22%.How often it rose: 62%
Typical return +1.9%, usual range −9% to +13%.How often it rose: 58%
Typical return +1.9%, usual range −12% to +13%.How often it rose: 60%
Typical return +0.9%, usual range −15% to +12%.How often it rose: 52%
Typical return +1.5%, usual range −9% to +31%.How often it rose: 56%
Typical return +5.7%, usual range −12% to +27%.How often it rose: 64%
Typical return +2.3%, usual range −11% to +17%.How often it rose: 57%
Typical return +4.5%, usual range −15% to +18%.How often it rose: 63%
Typical return −0.1%, usual range −15% to +15%.How often it rose: 50%
Typical return +0.8%, usual range −13% to +34%, limited history.How often it rose: 52%
Typical return +14.3%, usual range −9% to +38%.How often it rose: 79%
Typical return +6.0%, usual range −11% to +30%.How often it rose: 70%
Typical return +3.4%, usual range −20% to +26%.How often it rose: 60%
Typical return +0.8%, usual range −18% to +25%.How often it rose: 52%
Typical return +4.0%, usual range −19% to +36%, limited history.How often it rose: 62%
Typical return +24.7%, usual range −16% to +66%, limited history.How often it rose: 85%
Typical return +11.2%, usual range −12% to +57%, limited history.How often it rose: 69%
Typical return +7.4%, usual range −20% to +36%.How often it rose: 63%
Typical return +3.4%, usual range −21% to +35%, limited history.How often it rose: 59%
Know when the regime changes
TECH's typical 3-month return in past Mildly Off markets was −0.1%. Get an email the day the regime changes, and today's reading right away.
TECH: 1 month to 1 year, by market regime
| Regime | 1 month | 2 months | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| Risk-On | +1.1%55%53 | +3.2%62%38 | +5.7%64%27 | +14.3%79%18 | +24.7%85%10, limited history |
| Mildly On | +0.8%55%90 | +1.9%58%53 | +2.3%57%41 | +6.0%70%24 | +11.2%69%14, limited history |
| Neutral | +0.8%56%138 | +1.9%60%81 | +4.5%63%57 | +3.4%60%33 | +7.4%63%17 |
| Mildly Off Today | +0.1%50%83 | +0.9%52%52 | −0.1%50%39 | +0.8%52%23 | +3.4%59%13, limited history |
| Risk-Off | +2.3%61%26 | +1.5%56%18 | +0.8%52%14, limited history | +4.0%62%11, limited history | too little history: 8 past 12-month periods |
| All regimesbaseline | +0.7%55%213 | +1.8%58%107 | +2.9%58%73 | +4.3%63%36 | +8.6%65%18 |
Figures in italics have limited history (10 to 14 past periods); a dash means too little history.
TECH: Health Care stocks
| Stock | Risk-On | Mildly On | Neutral | Today Mildly Off | Risk-Off |
|---|---|---|---|---|---|
| Sector ETF (XLV) Health Care | +5.2% | +5.0% | +3.8% | +2.1% | +4.6%, limited history |
| DXCM Dexcom | +2.6% | +9.0% | +12.8% | +10.7% | +3.9%, limited history |
| LLY Eli Lilly | +3.6% | +4.9% | +4.4% | +6.7% | +5.4%, limited history |
| EW Edwards Lifesciences | +1.7% | +5.8% | +6.0% | +6.0% | +7.6%, limited history |
| MRK Merck | +3.4% | +3.4% | +1.4% | +6.0% | +5.0%, limited history |
| ALGN Align Technology | +5.9% | +8.5% | +6.7% | +5.8% | +17.2%, limited history |
| HCA HCA Healthcare | +12.7% | +9.9% | +4.5% | +5.3% | +8.1%, limited history |
| IDXX IDEXX Laboratories | +4.9% | +5.8% | +5.0% | +5.1% | +2.5%, limited history |
| REGN Regeneron | +0.7% | +7.9% | +5.4% | +4.9% | +2.4%, limited history |
| PODD Insulet | +7.1% | +7.3% | +6.5% | +4.8% | +10.9%, limited history |
| ABT Abbott Laboratories | +7.1% | +2.5% | +3.6% | +4.1% | +4.7%, limited history |
| ISRG Intuitive Surgical | +5.9% | +9.3% | +5.2% | +3.9% | +7.5%, limited history |
| CNC Centene | +4.9% | +4.7% | +6.0% | +3.8% | +3.9%, limited history |
| HUM Humana | +4.8% | +3.9% | +5.0% | +3.8% | +6.9%, limited history |
| COO Cooper Companies | +5.8% | +3.6% | +4.5% | +3.7% | −5.2%, limited history |
| BSX Boston Scientific | +5.0% | +1.2% | +3.4% | +3.6% | +7.9%, limited history |
| RMD ResMed | +2.8% | +7.4% | +3.7% | +3.5% | +4.2%, limited history |
| SYK Stryker | +4.4% | +3.7% | +3.3% | +3.5% | +2.9%, limited history |
| VEEV Veeva Systems | +2.7% | +3.7% | +3.3% | +3.5% | +7.7%, limited history |
| AMGN Amgen | +5.6% | +2.8% | +2.3% | +3.4% | +6.6%, limited history |
| CI Cigna | +5.6% | +5.0% | +6.2% | +3.4% | +3.6%, limited history |
| NVO Novo Nordisk | +2.6% | +5.3% | +5.0% | +3.0% | +8.2%, limited history |
| UNH UnitedHealth | +7.3% | +5.4% | +5.5% | +3.0% | +4.7%, limited history |
| STE Steris | +4.7% | +4.1% | +3.5% | +2.9% | +3.0%, limited history |
| UHS Universal Health Services | +8.9% | +6.7% | +2.5% | +2.9% | +0.2%, limited history |
| ZTS Zoetis | +2.4% | +1.6% | +4.4% | +2.9% | +6.3%, limited history |
| VRTX Vertex Pharmaceuticals | −1.1% | +4.0% | +4.7% | +2.8% | +4.5%, limited history |
| HSIC Henry Schein | +2.7% | +3.7% | +3.6% | +2.7% | +1.5%, limited history |
| MTD Mettler-Toledo | +8.9% | +7.4% | +3.9% | +2.5% | +10.0%, limited history |
| ZBH Zimmer Biomet | +4.7% | +1.2% | +2.3% | +2.5% | +2.3%, limited history |
| DGX Quest Diagnostics | +5.8% | +3.7% | +2.5% | +2.3% | +7.4%, limited history |
| MDT Medtronic | +5.9% | +4.2% | +2.7% | +2.3% | +4.1%, limited history |
| BDX Becton Dickinson | +1.2% | +2.2% | +2.8% | +2.2% | +2.2%, limited history |
| INCY Incyte | +5.4% | +3.9% | +3.2% | +2.2% | +3.6%, limited history |
| WST West Pharmaceutical Services | +3.9% | +5.9% | +8.3% | +2.2% | +5.9%, limited history |
| ILMN Illumina | +2.4% | +7.0% | +7.8% | +2.1% | −4.3%, limited history |
| IQV IQVIA | +8.9% | +6.9% | +3.4% | +2.0% | +9.4%, limited history |
| ELV Elevance Health | +7.8% | +6.6% | +4.1% | +1.9% | +4.1%, limited history |
| TMO Thermo Fisher | +6.3% | +6.5% | +6.0% | +1.9% | +5.8%, limited history |
| COR Cencora | +7.4% | +7.6% | +6.5% | +1.7% | +1.8%, limited history |
| DHR Danaher | +5.6% | +5.4% | +3.5% | +1.6% | +7.9%, limited history |
| BAX Baxter International | +0.7% | 0.0% | +3.1% | +1.4% | −2.6%, limited history |
| BIIB Biogen | +2.4% | +2.1% | +2.1% | +1.4% | +5.4%, limited history |
| JNJ Johnson & Johnson | +5.4% | +4.0% | +3.1% | +1.3% | +2.7%, limited history |
| A Agilent Technologies | +9.1% | +6.3% | +3.6% | +1.1% | +10.6%, limited history |
| MCK McKesson | +4.9% | +8.0% | +7.7% | +1.1% | +5.8%, limited history |
| ABBV AbbVie | +6.1% | +7.3% | +4.7% | +0.9% | +2.3%, limited history |
| WAT Waters | +8.4% | +7.0% | +3.3% | +0.9% | +4.9%, limited history |
| BMY Bristol Myers Squibb | +3.5% | +4.4% | +1.5% | +0.8% | +8.9%, limited history |
| CRL Charles River Laboratories | +11.3% | +7.7% | +4.2% | +0.6% | +5.8%, limited history |
| CAH Cardinal Health | +1.2% | +3.6% | +5.5% | +0.5% | +7.3%, limited history |
| RVTY Revvity | +4.4% | +5.4% | +3.8% | +0.4% | +6.1%, limited history |
| CVS CVS Health | +3.3% | +3.1% | +3.9% | +0.3% | +3.9%, limited history |
| LH Labcorp | +7.5% | +3.6% | +3.5% | +0.1% | +4.2%, limited history |
| DVA DaVita | +4.1% | +5.9% | +3.7% | 0.0% | +2.6%, limited history |
| PFE Pfizer | +4.9% | +3.3% | +2.5% | −0.1% | +5.3%, limited history |
| TECH Bio-Techne | +5.7% | +2.3% | +4.5% | −0.1% | +0.8%, limited history |
| GILD Gilead Sciences | +3.4% | +2.5% | +3.4% | −0.4% | +3.0%, limited history |
| MRNA Moderna | +13.9%, limited history | +18.9% | −13.5% | −1.4%, limited history | too little history: 8 past 3-month periods |
| VTRS Viatris | +0.6% | +5.6% | +4.2% | −1.4% | +3.6%, limited history |
Sector ETF: XLV's own typical return, the figure on its page.
TECH versus the market
TECH's typical 3-month return moves 1.4 times as much as the S&P 500's from one regime to another (TECH −0.1% to +5.7%, S&P 500 +1.7% to +6.0%).
Today's reading: 17th percentile (0 most Risk-Off, 100 most Risk-On), as of Friday's close, Oct 16.
Mildly Off has been TECH's weakest regime, as it has been for the market. That is today's regime. TECH has not shared the market's bounce from Risk-Off: its typical return there sat below its typical return across all markets.
How to read this
Base rates, not forecasts. These describe what TECH did after past days in each market regime. They are not forecasts: any single period can land far from the typical return, and a pattern from the last two decades may not hold in the years ahead.
The numbers. The typical return is the median: the middle outcome, with half of past periods better and half worse. The usual range holds 8 in 10 of them, from the 10th to the 90th percentile. Past periods are counted only when they do not overlap. Limited history means 10 to 14 such periods, shown in italics; too little history means fewer than 10, shown as a dash. TECH history from January 3, 2006, data through October 16, 2026.
About the same. The sentence under the title sets TECH's typical return in today's regime against its typical return across all markets; figures within half a point, or within a tenth of the larger one, count as about the same. The section on TECH versus the market sets how far its typical return moves across regimes against the S&P 500's move, which says nothing about better or worse overall.
Single stocks. For one stock the regime is usually a small nudge, not the main driver; its own trend dominates. Use it as context, not a reason to act. Why the mild-stress Dead Zone has been the weakest place to be.